Protein is everywhere right now. In bars, puddings, chips and in every other dietary recommendation. Yet the vast majority of the population already consumes more protein than recommended. A new review that evaluated around 350 studies calls this very trend into question — without proving the opposite. What this means in practice is more complicated than any headline suggests.

The provocative thesis

Knopf and Lamming from the University of Wisconsin-Madison published a review in Cell Press Blue in 2026 that makes for uncomfortable reading — at least for anyone currently recommending more protein to their clients.

The core argument: in animals, protein restriction extends both healthspan and lifespan. The hormone FGF21 is considered the central mediator. In these models, lower protein intake improves metabolism, alters cellular nutrient sensing, reduces cellular damage, and supports healthy cell function.

But — and this is the critical point — not all protein acts the same way.

The restriction of specific amino acids, particularly methionine, isoleucine, and the branched-chain amino acids (leucine, isoleucine, valine), accounts for much of these effects. It is therefore less about total quantity than about composition. Anyone who overlooks this draws the wrong conclusions from the review.

The apparent contradiction

At the same time, the evidence base for higher protein intake in older age is anything but weak.

Sarcopenia, the age-related loss of muscle mass, is a real clinical problem. Studies show that 1.2 g of protein per kilogram of body weight, compared to 0.8 g, can reduce muscle loss over three years by 40 percent. An analysis of the UK Biobank found a lower frailty risk with higher protein intake in older age.

Two recommendations that appear to contradict each other:

• Eat more protein for muscle preservation and frailty prevention.
• Eat less protein for metabolism, cellular health, and longevity.

Anyone looking for a simple answer here will not find one. That is not a weakness of science. It is an invitation to differentiate.

How this resolves

The review resolves the contradiction itself, in three places.

The source matters. Plant-based, not animal-based, protein is associated with reduced frailty risk. A Mediterranean-style, lower-protein diet was associated in studies with greater muscle mass and strength — not less. The amino acid profile of the source changes which signaling pathways are engaged.

Exercise changes the equation. Resistance training can largely compensate for muscle loss at lower protein intakes. Athletes often consume large amounts of protein without developing metabolic disease. Lamming suspects that regular physical activity protects against the negative effects of high protein intake and thereby considerably expands the scope for individual recommendations.

There is no blanket answer. Pregnant women, growing children, people in recovery, older adults at risk of sarcopenia but they often need more. Sedentary middle-aged adults with adequate protein intake may not benefit from protein-enriched products at all. The market suggests otherwise.

What the review is not

It is important to be clear here.

The review is not evidence that low protein intake makes people live longer. Almost all lifespan data come from animal models. The population of Okinawa, with its traditionally lower-protein diet, is considered an interesting pointer — not proof. And studies exist that show a positive effect of higher protein intake on longevity-relevant markers.

Lamming himself draws the decisive conclusion: protein recommendations must be individually tailored. Not only by age, but also by physical activity, metabolism, and context.

That is not a new idea. But it is one that is being systematically ignored in the current protein hype.

Where we are going with this at SLOW

This is precisely where the core of the SLOW approach lies: holistic and precise.

Precise means: there is no single protein recommendation for everyone. The right amount depends on age, training status, muscle mass, kidney function, metabolic condition, and individual goals. More protein combined with resistance training in older age is clearly effective against sarcopenia — this does not contradict the protein restriction data. They are two ends of the same personalized answer.

Holistic means: protein never acts in isolation. Quantity, source, amino acid profile, movement behavior, mTOR and FGF21 signaling pathways, kidney and metabolic status — these must be considered together. Anyone who only pulls the protein lever shifts multiple systems at once, without seeing where they are heading.

On the SLOW platform, health professionals translate exactly these layers of data into a recommendation that fits the individual. Not the trend. The biomarkers are available, the relationships are documented, the protocols are evidence-based. From data to results.

How do you individualize protein recommendations in practice — and which markers do you draw on beyond age and training status? Write it in the comments.

Source: Knopf BA, Lamming DW. The hallmarks of protein and amino acid restriction in aging and longevity. Cell Press Blue (2026). doi.org/10.1016/j.cpblue.2026.100079

Why gum inflammation is linked to heart disease, diabetes, and cognitive decline — and what this reveals about the interconnected body

What begins in the gums rarely stays there. Research over recent years has painted an increasingly clear picture: chronic gum disease is not merely a local problem. It is associated with systemic inflammation and a range of conditions outside the mouth — including cardiovascular disease, diabetes, cognitive decline, arthritis, and respiratory and chronic liver disease. For health professionals who take longevity seriously, this is not a footnote. It is a structural argument for integrating oral health as a systemic indicator into the patient history.

The oral microbiome: a complex ecosystem with systemic reach

Hundreds of bacterial species, fungi, and other microorganisms live in the mouth. Most are part of a healthy equilibrium. A smaller group, however, thrives below the gumline — inflaming tissue and driving conditions such as gingivitis and periodontitis.

Plaque plays a central role here: a biofilm that anchors bacteria to the tooth and makes them more resistant to saliva and mouthwashes. When plaque hardens into tartar, chronic local inflammation develops. In advanced periodontitis, this inflammation destroys the tissue and bone that hold the teeth in place — with consequences that extend well beyond the mouth.

The mechanism: how the mouth reaches the systemic circulation

The pathway is well described. When gum tissue is inflamed, the natural barriers are weakened. Even everyday actions — chewing, brushing, flossing — can repeatedly introduce small amounts of bacteria or bacterial components into the bloodstream.

This so-called bacteraemia, and the associated endotoxaemia, increases inflammatory activity in the vascular endothelium. Periodontal pathogens such as Porphyromonas gingivalis can directly activate endothelial cells, contributing to endothelial dysfunction — an early step in atherosclerosis. Periodontal bacteria have been detected in atherosclerotic plaques of clients who have had heart attacks.

The scientific basis is solid. Hajishengallis & Chavakis (Nat Rev Immunol, 2021) describe both local and systemic mechanisms linking periodontitis to inflammatory comorbidities. A recent paper on oral dysbiosis as a systemic trigger complements this by documenting the microbial mechanisms of cardiovascular disease with biological precision.

The question of causality

For a long time, the connection between oral health and systemic disease was considered a purely associative one. People with poor oral health often present with other risk factors as well. More recent interventional and animal studies, however, provide biologically plausible mechanisms that go beyond correlation.

Particularly telling: targeted treatment of periodontitis demonstrably improves surrogate markers of systemic disease. In studies, intensive periodontal therapy reduced both blood pressure and inflammatory markers such as interleukin-6 and hsCRP. Reducing inflammation in the mouth appears to reduce systemic inflammatory activity as well.

This is not coincidence. It is biology.

What this means in practice: holistic and precise

The oral microbiome is a prime example of an approach that takes longevity seriously: holistic in perspective, precise in methodology.

Holistic means: the body does not operate in separate compartments. The mouth is not an isolated unit but an entry point into the systemic circulation. Inflammation is the shared currency through which periodontitis, cardiovascular risk, insulin resistance, and neuroinflammatory processes communicate with one another. Anyone who thinks about health optimisation at the organ level will consistently underestimate these systemic connections.

Precise means: these connections are measurable. Systemic inflammatory markers such as hsCRP and interleukin-6, their relationship to cardiovascular and metabolic values, and in the future also salivary microbiome analyses — saliva is considered a promising early indicator of vascular risk. A data point that is rarely collected in conventional health monitoring.

Common questions from practice

Should periodontal status be part of the patient history?
Yes — not as a specialist dental question, but as a systemic inflammation indicator. Periodontal status provides context for inflammatory markers, cardiovascular values, and metabolic parameters.

Which biomarkers are relevant in this context?
hsCRP and interleukin-6 are established markers of systemic inflammatory activity and can point to oral dysbiosis as a contributing factor. Cardiovascular and metabolic markers are a useful complement to complete the overall picture.

How can this be integrated into existing care concepts?
Through a structured patient history that explicitly captures periodontal status, and by linking this with inflammation and metabolism data within the monitoring protocol. Not as an isolated finding, but in the context of the system.

Conclusion: oral health as a systemic indicator

The connection between oral and systemic health is evidence-based, biologically plausible, and clinically relevant. For health professionals who support clients in a holistic way, the mouth is not a peripheral topic — it is a window into the inflammatory status of the entire organism.

In an integrated platform, precisely these overlooked puzzle pieces come together into a coherent picture. Not as an isolated finding, but in the context of the system. From data to outcomes. Measurable. Documented. Sustainable.

Do you include oral health and periodontal status in your patient history — and how do you connect this with inflammatory markers such as hsCRP or IL-6? Share your thoughts in the comments.

Why a Berlin study shows that caregiving reduces mortality risk — and why it requires no family relationship.

The Grandmother Hypothesis: Elegant theory, unsatisfying answer

There is an evolutionary theory that explains why women live for decades after menopause. The so-called Grandmother Hypothesis holds that postmenopausal women maximised their fitness by helping raise their grandchildren. Healthier, longer-lived grandmothers passed their genes on to more descendants — and so a longer lifespan became established.

Sounds plausible. But what does that mean today? And what exactly is the mechanism?

One of the most methodologically rigorous studies on this question offers a surprisingly precise answer. It is not grandparenthood itself that extends life. The active, caregiving role does.

What the study examined — and how

An international research team led by Sonja Hilbrand and David Coall, with participation from the University of Basel, the Max Planck Institute for Human Development, and Humboldt-Universität Berlin, analysed data from the Berlin Aging Study. Over 500 people between the ages of 70 and 103, observed over a period of nearly 20 years (1990 to 2009).

One methodological decision is particularly relevant. The researchers excluded grandparents who held primary responsibility for their grandchildren. The study examined exclusively occasional, non-custodial caregiving. The usual stepping in, not full-time upbringing. This restriction is not incidental. It is the key to interpretation.

The result: 37 percent lower mortality risk

Hilbrand et al. 2017 documented the following: grandparents who occasionally cared for their grandchildren had a 37 percent lower mortality risk than grandparents without caregiving responsibilities. The same effect appeared in comparison to people without grandchildren.

The association remained statistically stable after the researchers controlled for physical health, age, socioeconomic status, and characteristics of children and grandchildren. This is not a marginal effect. It is a robust finding.

The decisive point: Caregiving is the active ingredient, not the family tree

This is where it becomes particularly relevant for us as practitioners. The effect is not tied to family relationship.

The same analysis showed that childless older adults who supported others in their social environment also had a lower mortality risk. The authors hypothesise a neural and hormonal system originally rooted in parenthood. It is activated by caregiving behaviour in general. It promotes prosocial behaviour toward relatives and non-relatives alike.

Put differently: the system does not ask about the family tree. It responds to the action.

The honest nuance: More is not better

It would be a mistake to read this finding as an argument for maximum caregiving. The study's authors explicitly emphasise that a moderate level of caregiving produces positive effects. Intensive, sustained full-time caregiving, by contrast, generates stress load that takes a physical and mental toll. That is precisely why grandparents with custodial responsibility were excluded from the analysis.

This is not a footnote. It is a central finding. The dose-response curve is not linear. It has an optimum, and beyond that point the effect reverses.

It is also worth noting: this is an observational finding, not an experiment. Reverse causality is conceivable. Healthier people may simply be more able to help. The authors therefore speak of association — and that is how we should frame it in communication with clients.

What this means for health coaching

This finding fits into a picture that we at SLOW pursue systematically. Longevity is not a pure biomarker topic. Social integration, the sense of being needed, the experience of meaning, and the assumption of responsibility are all associated with hard endpoints. Anyone who excludes this dimension from health coaching overlooks one of the most powerful levers available.

Concretely, this means two things.

Think holistically: Caregiving balance, social role, and the subjective experience of meaning belong in the anamnesis. Not as an afterthought, but as part of the system. A client who has recently slipped into a caregiving role for a parent carries a different stress load than someone who looks after grandchildren once a week. Both are caregiving. The difference lies in degree and in control.

Stay precise: The individual situation determines where a person sits on this curve. Stress load, HRV, sleep quality, and self-reported social role need to be considered together. Not in isolation. Only the interplay of these data points produces a reliable picture.

In the SLOW platform, health professionals can integrate exactly these non-biochemical factors into a coherent assessment. Not because it sounds appealing, but because the evidence justifies it.

FAQ: Common questions about caregiving and longevity

Does grandparenthood generally extend life?
No. The study shows that the biological role is not what matters — what matters is the active practice of caregiving. Grandparents without caregiving responsibilities showed no comparably lower mortality risk.

Does the effect apply to people without grandchildren or children?
Yes. Childless older adults who supported others in their social environment also showed a lower mortality risk in the same study. Caregiving is the active ingredient, not family relationship.

Is more caregiving better for health?
No. The study shows explicitly that intensive, sustained caregiving — such as serving as the primary caregiver — is associated with increased stress load and cancels out the protective effect. The optimum lies in moderate, self-directed engagement.

How can I as a practitioner account for this factor when working with clients?
By systematically including social role and caregiving balance in the anamnesis and considering them alongside objective biomarkers such as HRV and sleep quality. Only the full picture allows for a precise assessment of actual stress load.

Source

Hilbrand S, Coall DA, Gerstorf D, Hertwig R. Caregiving within and beyond the family is associated with lower mortality for the caregiver. A prospective study. Evolution and Human Behavior, 38(3), 397–403 (2017). sciencedirect.com

Do you systematically include social role and caregiving balance in your anamnesis — and if so, how do you capture them? Write it in the comments.

Why high blood pressure goes unnoticed, why that is dangerous, and what the 2025 guidelines recommend in response.

Ask the average person how they would know their blood pressure is fine. The answers tend to sound the same. I feel calm. I'm not stressed. I would notice if something were wrong.

That is one of the most common and most costly misconceptions in health.

A condition without a warning signal

High blood pressure gives almost no indication that something is wrong. That is precisely why the US health authority CDC calls it the silent killer. For years it strains the heart, arteries, and kidneys while a person feels completely normal. By the time a symptom appears, the damage is often already done.

Nearly half of all adults have elevated blood pressure. A large proportion of them do not know it. Not out of carelessness, but simply because there was nothing to notice.

The reason is straightforward: the body has no sensor for blood pressure the way it has one for a stubbed toe or a hot stovetop. Feeling relaxed says literally nothing about the number on the cuff. The feeling and the value are two separate things with no connection to each other.

Progress came through measuring, not through feeling

Medicine did not improve on this topic by teaching people to sense pressure more accurately. It improved through consistent measurement and observation over time.

The 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults has established home blood pressure measurement as the diagnostic standard, and for good reason. A single reading taken at a doctor's office is often less accurate than the average of several readings taken at home. Two well-known phenomena explain why.

The so-called white coat effect: anxiety in the clinic drives values up, even though everything sits within the normal range in everyday life. The opposite is masked hypertension: clinic readings look unremarkable, but everyday pressure is elevated. Both patterns are only visible outside the clinic. Both can be clinically relevant.

Measuring correctly

Anyone measuring at home should pay attention to the right device and the right technique. According to the guideline, a validated upper-arm device is essential. Wrist and smartwatch measurements are not yet reliable enough for dependable diagnostics.

The technique is straightforward:

• Sit quietly, feet flat on the floor, arm supported at heart level
• Rest for five minutes before measuring, do not speak
• Take two readings one minute apart and average them
• Repeat this on several days

For reference: below 120/80 mmHg is considered normal. From 130/80 mmHg upward, a conversation with a doctor is worthwhile. Not as cause for alarm, but as a sensible next step.

The good news

Finding an elevated reading is not a reason to panic. Blood pressure is one of the most modifiable values in the entire health picture. Diet, physical activity, weight, and reduced salt intake all have an effect. A measurable one.

The guideline is specific here: for individuals with low cardiovascular risk and a reading from 130/80 mmHg, a three-to-six-month trial of lifestyle changes is recommended before medication enters the picture. Only if the value remains elevated after that does pharmacological treatment begin. This is not minimisation. It is evidence-based prioritisation.

What we are getting at with SLOW

This is precisely where preventive health optimisation shows what it actually means in practice.

Precise means: a single snapshot does not produce a reliable picture. A trend does. Home measurement series, supplemented where needed by ambulatory 24-hour monitoring, alongside resting heart rate and HRV. That is how a number becomes a signal that a health professional can meaningfully interpret. Data collected over time is data you can work with.

Holistic means: blood pressure is not an isolated value. It sits at the intersection of sleep quality, stress load, insulin sensitivity, sodium-potassium balance, alcohol consumption, body composition, and kidney function. Lowering it means changing not one variable but a system. That is precisely why lifestyle levers are so powerful in combination. And precisely why it takes guidance that keeps the full picture in view.

Within the SLOW platform, health professionals translate these layers of data into a protocol that fits the individual. A silent risk becomes a visible, manageable trajectory. From data to results.

How do you integrate home blood pressure measurement series into your practice, and at what point in the trend do you act? Write it in the comments.

This is a sensitive health topic. This post does not replace medical advice. For elevated readings or symptoms, assessment by a doctor is the right course of action.

Source: 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. Hypertension (2025). DOI: 10.1161/HYP.0000000000000249

Why the oldest people in Japan have an abundance of a rare immune cell — and why this is not yet a blueprint for a long life.

What happens when the immune system reaches 110 years old?

The standard answer is: it declines. Researchers call this process immunosenescence — the gradual reduction of immune function with advancing age. More infections, higher cancer risk, disrupted self-regulation.

But then there are these 146 people.

Across Japan in 2015, more than 61,000 centenarians were living. Supercentenarians — people aged 110 and older — numbered just 146 among them. A tiny group. And yet they fascinate researchers, because they do something that isn't supposed to happen: they remain remarkably healthy into extreme old age. Cancer, heart disease, stroke — late or not at all.

A Japanese research team took a close look at their immune systems. What it found was not what most would have expected.

The finding: an immune cell that is normally rare

Hashimoto et al. analyzed over 61,000 blood cells in a 2019 single-cell analysis from supercentenarians and younger comparison subjects. The result was clear: the oldest people carry an unusually high number of an immune cell that is barely present in most people.

These cells are called cytotoxic CD4 T lymphocytes, or CD4 CTLs for short.

For comparison: in younger adults, CD4 CTLs typically make up less than 5 percent of all CD4 T cells. In supercentenarians, a follow-up study from Osaka University published in 2026 found a median of around 17.6 percent — and this proportion increases further with extreme age.

What makes CD4 CTLs so distinctive

Understanding why this matters requires a brief look at immunobiology.

The immune system classically recognizes two types of T cells with different roles. CD4 cells coordinate the immune response — they are the conductors. CD8 cells directly kill infected or malignant cells — they are the executors.

CD4 CTLs are a kind of hybrid. They can do both: coordinate and kill directly. And in the supercentenarians studied, they show no signs of exhaustion — a state in which immune cells become blunted and ineffective after prolonged activation.

A further finding is particularly notable: the molecular receptor sequences of these cells resemble patterns found in cancer patients — even though none of the supercentenarians studied had ever developed those cancers. The researchers suspect that the cells recognize and eliminate malignant cells early, before a clinical tumor forms.

Lead author Kosuke Hashimoto frames the core idea this way: immune aging may be less a matter of wear and tear than of reorganization. The immune system restructures itself.

What this study is not — and why that matters

This is the point that is almost always lost in popular accounts of this research.

The researchers state explicitly: their work does not prove causality. The study does not show that a higher proportion of CD4 CTLs protects against cancer or causes a long life. It shows a correlation — found in an extremely small sample of people who are already biological outliers within their species.

Whether these cells are a cause, a companion feature, or a consequence of healthy aging remains an open question.

There is no validated intervention that selectively increases CD4 CTLs. There is no supplement that reproduces this effect. Anyone drawing an actionable recommendation from this study is overinterpreting the evidence.

What remains is a fascinating area of research. Nothing more — but nothing less either.

What this means for working with clients

This is precisely where the real challenge lies for health professionals.

Longevity research has become more visible. Clients read studies, follow scientists on social media, and bring findings into consultations. Sometimes with the expectation that an interesting result can be translated directly into a protocol.

The ability to distinguish between a research signal and an applicable recommendation is one of the most important clinical competencies — and at the same time one of the most difficult to communicate.

A median value from a handful of people is not a guide to action. Not even when the study has appeared in a respected journal.

The principle behind the finding

What supercentenarian research teaches us nonetheless is something fundamental.

Healthy aging is not a state explained by a single marker. It is the result of a well-regulated system operating over decades. Immune function does not stand in isolation — it is interwoven with chronic inflammation, metabolism, sleep, movement, stress, nutrition, and the body's capacity to respond to disruption.

Supercentenarians are not a recipe. They are a model. A pointer toward what healthy aging as an overall state can look like — not as the effect of a single cell.

In working with clients, this means: anyone who takes immune function seriously in the context of longevity works with validated markers whose relationship to hard endpoints is documented — and remains open at the same time to what research will show next.

From data to outcomes. Measurable. Documented. Sustainable.

Frequently asked questions about CD4 CTLs and supercentenarians

What are cytotoxic CD4 T cells (CD4 CTLs)?
CD4 CTLs are a rare subgroup of T lymphocytes capable of performing both coordinating and directly cytotoxic functions. They combine properties of classical CD4 helper cells and CD8 killer cells.

Why do supercentenarians have so many CD4 CTLs?
This has not yet been conclusively explained. Research shows a strong correlation, but no proven causality. Whether the elevated number of these cells is a cause or a companion feature of healthy aging remains an open question.

Can CD4 CTLs be increased through supplements or interventions?
No — there is currently no validated intervention that reproduces this effect in a targeted and safe way. Anyone marketing products along these lines is going beyond what the current evidence supports.

What does immunosenescence mean?
Immunosenescence refers to the age-associated decline in immune function. It increases susceptibility to infections, cancer, and autoimmune conditions. Supercentenarian research suggests that immune aging is not necessarily a linear decline, but may also include adaptive reorganization processes.

A question for the community

How do you handle clients who read fascinating longevity studies and want to derive measures from them that the evidence does not yet support? Write it in the comments.

This post contextualizes current research and does not replace medical advice. The studies cited do not establish causality between CD4 CTLs and longevity. No supplements or treatments should be derived from these findings.

Sources

• Hashimoto K et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. PNAS, 116(48), 24242–24251 (2019).
• Hashimoto K et al. CD4 CTLs in supercentenarians. Signs of adaptive expansion in healthy aging. Cell Reports (2026).

When people talk about gut health, they usually talk about bacteria. Too little diversity, too many opportunistic pathogens, disrupted barrier function driven by dysbiosis-related inflammation. That is not wrong — but it may be thinking too narrowly. A new paper in Nature Aging suggests that systemic inflammation ages intestinal stem cells directly through the mitochondria. And that shifts the question fundamentally: not only which bacteria live in the gut. But whether the cells that build the gut in the first place are still metabolically fit enough to maintain that environment.

What the study shows · and why it is elegant

Wang et al. (Nature Aging, 2026) describe a causal chain clear enough to make you wonder why we did not see it this way sooner.

Aging increases TNF-TNFR1 signaling. That signal reduces mitochondrial function in intestinal stem cells. Reduced mitochondrial function impairs fatty acid oxidation. And the result: the regenerative capacity of intestinal stem cells declines, the epithelium thins, and barrier function deteriorates.

No bacterium is the trigger in this chain. The trigger is systemic inflammation — specifically a cytokine signal that acts on intestinal stem cells via the bloodstream.

The parabiosis experiment: the decisive evidence

The most compelling experiment in the study is a parabiosis trial. Young mice whose circulatory systems were connected to those of old mice showed impaired intestinal stem cell function.

That is remarkable. Part of the aged gut phenotype could be transferred — not through bacteria, but through blood. Through the systemic environment.

The researchers were able to trace this effect back to TNF signaling. Anti-inflammatory interventions — including TNF antibodies — restored stem cell function. A TNFR1 knockout protected young intestinal stem cells from the old systemic environment. And particularly relevant for practice: selectively promoting mitochondrial fusion measurably improved the function of aged intestinal stem cells.

Why this challenges our categories

In longevity medicine, we often think in separate categories: inflammaging. Mitochondrial dysfunction. Stem cell exhaustion. Dysbiosis. Barrier disruption. That is didactically useful — but biologically imprecise.

This study shows that these phenomena are not parallel problems. They are parts of a causal network. Inflammation acts on mitochondria, mitochondria shape stem cell function, stem cells build the epithelium, and the epithelium defines the habitat of the microbiome.

We have described elsewhere how the hallmarks of aging form a single module when analyzed as a network. This study provides a concrete, organ-specific example of exactly that.

And it raises a question that is asked too rarely in nutrition and microbiome research: what if a young gut is not primarily a matter of having the right bacteria — but of the metabolic fitness of the cells that create the ecosystem in which those bacteria live?

The microbiome acts on the host — that is established. But the reverse arrow exists as well: the host's metabolism shapes the habitat of the microbiome. That second arrow receives too little attention.

What this means for practice — and where SLOW comes in

For health professionals managing gut health comprehensively, this means a concrete expansion of perspective.

Systemic inflammation markers such as hsCRP and TNF-alpha are not only cardiovascular risk markers. They are potentially also indicators of the aging state of intestinal stem cells. Metabolic values pointing to mitochondrial efficiency belong in the same picture as microbiome analyses. Not side by side, but as a connected chain.

That is precisely the approach we take at SLOW: not bacteria versus inflammation versus mitochondria, but an integrated picture drawn from markers read together. Systemic inflammation parameters, metabolic data, and — looking ahead — markers of mitochondrial function as parts of a chain that a health professional assesses together and translates into an evidence-based protocol.

That is not overengineering. That is precision that matches the current state of research.

A necessary caveat

This study works with mouse data. The translation of the described mechanisms to humans has not yet been demonstrated. The value of this work lies in the mechanism and the direction of thinking — not in a ready-made clinical recommendation.

But the direction of thinking is clear: gut health that is to be sustainably maintained at the stem cell level requires more than probiotics and dietary fiber. It requires a systemic perspective on inflammation and metabolism.

Conclusion: from the microbiome to a systemic perspective

Treating gut health as a purely microbiome problem underestimates the complexity of the system. Wang et al. show that systemic inflammation acts directly on intestinal stem cells through mitochondrial mechanisms — and therefore on the very foundation on which the microbiome exists at all.

For practitioners who want to support clients on gut and immune health in an evidence-based way, this means: the relevant markers are not found only in stool. They are in the blood. And they can be measured, interpreted, and translated into protocols — when the right system is in place.

This post is a scientific commentary based on an animal study and does not replace medical advice.

Do you already think about gut health in your practice beyond the microbiome — combining it with inflammation and metabolic markers? Share your thoughts in the comments.

The conversation around gut health gets loud quickly. Probiotics, strains, diversity, fermentation, butyrate. Yet a growing body of research keeps pointing back to something fundamental: what is eaten matters. Not as a blanket recommendation, but as a measurable mechanism.

A recent meta-analysis offers concrete answers to that question. It also corrects a widespread oversimplification.

What the meta-analysis shows

Mao et al. (2024) published a methodologically rigorous meta-analysis of randomized controlled trials in Critical Reviews in Food Science and Nutrition. The focus: how do polyphenols affect the gut microbiome and inflammatory markers in people with overweight or obesity?

Study quality was assessed using the GRADE standard, one of the most stringent evaluation frameworks in evidence-based medicine.

Participants consumed an average of around 452 mg of phenolic compounds per day over a period of approximately five weeks. The sources: berries, tea, pomegranate, and olive oil.

The findings

The polyphenols shifted the composition of the microbiome in a measurably favorable direction. The proportion of unfavorable bacterial strains declined, and the ratio of major bacterial groups improved.

Particularly relevant is the inflammation finding. The analysis showed a significant reduction in circulating lipopolysaccharides, or LPS. LPS are components of the outer membrane of gram-negative bacteria. When the gut barrier is permeable, they enter the bloodstream and trigger chronic, low-grade inflammation. Lower LPS levels in the blood point to a tighter, more functional gut barrier.

This is not a marginal effect. Chronically elevated LPS levels are associated with metabolic dysfunction, insulin resistance, and systemic inflammation. A reduction in this marker after five weeks of polyphenol intake is a measurable signal.

The nuance that often gets told wrong

Here is where things diverge from a common claim.

In this analysis, polyphenols did not significantly increase the production of short-chain fatty acids, including butyrate. Butyrate is the compound credited with most of the gut's protective effects: energy supply for colonocytes, barrier stabilization, and anti-inflammatory signaling.

Practitioners who have explained to clients that berries boost butyrate will not find support for that in this dataset over five weeks. Polyphenols shift the composition of bacteria. They do not automatically supply the fuel those bacteria need to produce butyrate.

For context: the evidence base is not uniform. Other meta-analyses do show increases in acetate and butyrate for certain polyphenol sources. That is precisely why a differentiated view is worthwhile. The blanket berries-equal-butyrate equation is a simplification that does not reflect the complexity of the system.

The two-step approach that actually makes sense

The evidence points to a logical structure. Two steps that belong together.

Step one: Polyphenol-rich foods

They shift who lives in the gut. Favorable bacterial strains gain ground, unfavorable ones lose it. Good sources: blueberries, strawberries, raspberries, cherries, plums, apples, spinach, artichokes, olives, beans, dark chocolate, coffee, and tea.

Step two: Resistant starch and soluble fiber

The shifted bacteria need fuel. The most important fuel for butyrate production is resistant starch. It passes through the small intestine undigested and is fermented only in the large intestine. Good sources: green bananas, beans, and cooked-then-cooled rice, pasta, or potatoes.

The two steps do not compete. They are the same strategy applied at different points in the system. Polyphenols shift the composition. Fiber feeds what that shift produces. Anyone who takes only one of the two steps leaves the potential of the other unused.

What we are getting at with SLOW

This is precisely where a holistic and at the same time precise approach to health consulting proves its value.

Holistic means: gut health is not a single lever. Composition and fuel belong together, and both are directly connected to inflammatory load, barrier function, and metabolism. Anyone who intervenes at only one point is not seeing the full system.

Precise means: the same serving of berries does not produce the same change in everyone. Starting microbiome and barrier function vary between individuals. Inflammatory markers tracked over time, LPS, high-sensitivity CRP, zonulin, say more than any blanket recommendation.

On the SLOW platform, health professionals translate exactly these data layers into recommendations that fit the individual. Not as a one-size-fits-all protocol, but as individually tailored guidance based on measurable markers and documented over time. From data to results.

How do you advise your clients on the interplay between polyphenols and fiber? And do you draw on barrier or inflammatory markers to track progress? Share your thoughts in the comments.

Source

Mao T, Zhang Y, Kaushik R, et al. Effects of polyphenols on gut microbiota and inflammatory markers in individuals with overweight or obesity. A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition (2024).

Why the consistency of sleep timing predicts mortality risk more strongly than sleep duration — and what that means for working with your clients.

Almost every sleep recommendation revolves around a number. Seven to nine hours. Duration is treated as the decisive measure. A large analysis of more than 60,000 people calls exactly that focus into question. The findings are precise enough to change how we assess sleep in health optimization.

What the study measured

Windred and colleagues from Monash University and Harvard Medical School analyzed data from the UK Biobank: 60,977 individuals, over 10 million hours of objectively recorded sleep-wake patterns via actigraphy. Not self-reported questionnaires, but measured movement data.

From this data they calculated the Sleep Regularity Index (SRI): a measure of how similar a person's sleep timing is from one day to the next. They then compared what better predicts mortality risk — regularity or duration.

The result is unambiguous.

The numbers that matter

People with the most regular sleep timing had a substantially lower risk compared to those with the most irregular patterns — adjusted for age, sex, ethnicity, socioeconomic factors, and lifestyle and health variables:

• All-cause mortality: 20 to 48 percent lower
• Cancer mortality: 16 to 39 percent lower
• Cardiometabolic mortality: 22 to 57 percent lower

The key finding: sleep regularity predicted all-cause mortality more accurately than sleep duration. Irregular sleepers carry a risk that sufficient hours alone cannot offset.

Source: Windred et al. 2024 – Sleep regularity and mortality (Oxford Academic)

Why the body rewards rhythm

The body runs on an internal clock. Circadian rhythmicity governs hormone release, body temperature, metabolism, immune function, and blood pressure across the day — in a coordinated, not isolated, way. Regular sleep timing keeps this clock on track. Constantly shifting times throw it off.

This state is comparable to what is known as social jetlag: the body is living in two different time zones simultaneously — biological and social. That has measurable consequences for inflammatory load, blood glucose regulation, and cardiovascular parameters.

A simple, evidence-based anchor: wake up at the same time each morning and seek daylight early. Morning light is the strongest signal that recalibrates the internal clock each day. A tolerance window of around 30 minutes is considered unproblematic. The occasional exception is too.

What this study can — and cannot — tell us

Honest context matters here.

This is an observational study. It shows a strong, cleanly adjusted association — but not proof of causality. Reverse causality is plausible: an emerging illness could make sleep more irregular while also increasing mortality risk. The cohort was also on average over 60 years old, which limits how directly the findings transfer to younger client groups.

Even so, the message holds. Sleep regularity is a free, realistically actionable lever. It is also one of the few that can be made visible with objective data.

What this means in practice

This is where the difference between a lifestyle tip and a measurable intervention becomes clear.

Holistic: Sleep regularity reaches far beyond sleep itself. It touches hormone profiles, blood glucose regulation, blood pressure, inflammatory markers, and mood regulation. The principle is the same one we see across other domains — whether gut microbiome, training adaptation, or behavior: consistency over time outperforms the single large effort. The body rewards rhythm.

Precise: Regularity can be measured. Actigraphy and wearable data make sleep-wake consistency visible. HRV and resting heart rate reflect actual recovery quality. A vague intention becomes a trajectory you can read, interpret, and act on as a health professional.

Behavior-anchored: A good intention falls apart without structure. That is why the SLOW Concierge makes it possible to export measures as calendar entries and track them through streaks. A fixed wake time may be the most worthwhile habit to anchor this way. From data to results.

Frequently asked questions

What is the Sleep Regularity Index?
The Sleep Regularity Index (SRI) is a scientific measure that describes how similar a person's sleep and wake times are from one day to the next. A high SRI means high consistency — the same bedtime, the same wake time. It is calculated from actigraphy data and is considered a more objective measure than self-reported sleep duration.

Is sleep regularity more important than sleep duration?
The study by Windred et al. (2024) shows that the Sleep Regularity Index predicts all-cause mortality more accurately than sleep duration. That does not mean duration is irrelevant — but regularity is an independent factor that has been underestimated until now.

How much variation in sleep timing is acceptable?
The current research suggests that a tolerance window of around 30 minutes is unproblematic. Occasional exceptions — such as on weekends — carry little weight as long as the underlying consistency is maintained.

How can sleep regularity be tracked in client work?
Wearables with sleep tracking and actigraphy data provide the most objective foundation. HRV values and resting heart rate offer additional insight into actual recovery quality — independent of sleep duration alone.

This article contextualizes research findings and does not replace medical advice. Health decisions should always be made in consultation with qualified professionals.

How do you track sleep regularity in practice — and do you work more with fixed times or tolerance windows? Share your thoughts in the comments.